Page last updated: 2024-09-04

gadolinium dtpa and 3-carbamoyl-2,2,5,5-tetramethyl-1-pyrrolidinyl-n-oxyl

gadolinium dtpa has been researched along with 3-carbamoyl-2,2,5,5-tetramethyl-1-pyrrolidinyl-n-oxyl in 2 studies

Compound Research Comparison

Studies
(gadolinium dtpa)
Trials
(gadolinium dtpa)
Recent Studies (post-2010)
(gadolinium dtpa)
Studies
(3-carbamoyl-2,2,5,5-tetramethyl-1-pyrrolidinyl-n-oxyl)
Trials
(3-carbamoyl-2,2,5,5-tetramethyl-1-pyrrolidinyl-n-oxyl)
Recent Studies (post-2010) (3-carbamoyl-2,2,5,5-tetramethyl-1-pyrrolidinyl-n-oxyl)
12,6546644,0514808

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hyodo, E; Hyodo, F; Krishna, MC; Matsumoto, K; Mitchell, JB; Murugesan, R; Subramanian, S1
Aoki, I; Bakalova, R; Hadjidekov, G; Ishii, I; Kitada, M; Saga, T; Tomizawa, A; Zhelev, Z1

Other Studies

2 other study(ies) available for gadolinium dtpa and 3-carbamoyl-2,2,5,5-tetramethyl-1-pyrrolidinyl-n-oxyl

ArticleYear
Monitoring redox-sensitive paramagnetic contrast agent by EPRI, OMRI and MRI.
    Journal of magnetic resonance (San Diego, Calif. : 1997), 2008, Volume: 190, Issue:1

    Topics: Ascorbic Acid; Contrast Media; Cyclic N-Oxides; Electron Spin Resonance Spectroscopy; Gadolinium DTPA; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Nitrogen Oxides; Oxidation-Reduction; Phantoms, Imaging; Pyrrolidines; Triacetoneamine-N-Oxyl

2008
Nitroxide derivatives for imaging of hypercholesterolemia-induced kidney dysfunction and assessing the effectiveness of antilipidemic drugs.
    Molecular pharmaceutics, 2011, Oct-03, Volume: 8, Issue:5

    Topics: Animals; Anticholesteremic Agents; Azetidines; Cholesterol; Cholesterol, Dietary; Cholestyramine Resin; Contrast Media; Cyclic N-Oxides; Drug Monitoring; Ezetimibe; Gadolinium DTPA; Humans; Hypercholesterolemia; Kidney; Kinetics; Magnetic Resonance Imaging; Male; Mice; Mice, Inbred C57BL; Nitrogen Oxides; Pyrrolidines; Renal Insufficiency

2011